Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

NCT04319159 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses

Interventions

COMBINATION_PRODUCT: BF-200 ALA and red light LED lamp

Sponsor

Biofrontera Bioscience GmbH